These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
511 related items for PubMed ID: 19720489
1. Comparison of quantitative dynamic susceptibility-contrast MRI perfusion estimates obtained using different contrast-agent administration schemes at 3T. Wirestam R, Thilmann O, Knutsson L, Björkman-Burtscher IM, Larsson EM, Ståhlberg F. Eur J Radiol; 2010 Jul; 75(1):e86-91. PubMed ID: 19720489 [Abstract] [Full Text] [Related]
2. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T. Thilmann O, Larsson EM, Björkman-Burtscher IM, Ståhlberg F, Wirestam R. J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539 [Abstract] [Full Text] [Related]
3. Dynamic susceptibility contrast MRI with a prebolus contrast agent administration design for improved absolute quantification of perfusion. Knutsson L, Lindgren E, Ahlgren A, van Osch MJ, Bloch KM, Surova Y, Ståhlberg F, van Westen D, Wirestam R. Magn Reson Med; 2014 Oct; 72(4):996-1006. PubMed ID: 24285621 [Abstract] [Full Text] [Related]
4. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, Hohlfeld R, Reiser M, Glaser C. Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532 [Abstract] [Full Text] [Related]
5. Reduction of arterial partial volume effects for improved absolute quantification of DSC-MRI perfusion estimates: comparison between tail scaling and prebolus administration. Knutsson L, Lindgren E, Ahlgren A, van Osch MJ, Markenroth Bloch K, Surova Y, Ståhlberg F, van Westen D, Wirestam R. J Magn Reson Imaging; 2015 Apr; 41(4):903-8. PubMed ID: 24664642 [Abstract] [Full Text] [Related]
10. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T. Essig M, Lodemann KP, Le-Huu M, Brüning R, Kirchin M, Reith W. Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908 [Abstract] [Full Text] [Related]
11. [Comparison of MultiHance and Gadovist for cerebral MR perfusion imaging in healthy volunteers]. Essig M, Lodemann KP, LeHuu M, Schönberg SO, Hübener M, Van Kaick G. Radiologe; 2002 Nov; 42(11):909-15. PubMed ID: 12458444 [Abstract] [Full Text] [Related]
13. Absolute quantification of cerebral blood flow in normal volunteers: correlation between Xe-133 SPECT and dynamic susceptibility contrast MRI. Knutsson L, Börjesson S, Larsson EM, Risberg J, Gustafson L, Passant U, Ståhlberg F, Wirestam R. J Magn Reson Imaging; 2007 Oct; 26(4):913-20. PubMed ID: 17896379 [Abstract] [Full Text] [Related]
14. Voxel-specific brain arterial input functions from dynamic susceptibility contrast MRI and blind deconvolution in a group of healthy males. Nordli H, Taxt T, Moen G, Grüner R. Acta Radiol; 2010 Apr; 51(3):334-43. PubMed ID: 20192895 [Abstract] [Full Text] [Related]
15. Arterial input function measurements for bolus tracking perfusion imaging in the brain. Kellner E, Mader I, Mix M, Splitthoff DN, Reisert M, Foerster K, Nguyen-Thanh T, Gall P, Kiselev VG. Magn Reson Med; 2013 Mar 01; 69(3):771-80. PubMed ID: 22610991 [Abstract] [Full Text] [Related]
16. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI. Newman GC, Hospod FE, Patlak CS, Fain SE, Pulfer KA, Cook TD, O'Sullivan F. J Cereb Blood Flow Metab; 2006 Jun 01; 26(6):760-70. PubMed ID: 16319833 [Abstract] [Full Text] [Related]
17. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI. Wong AM, Yan FX, Liu HL. J Magn Reson Imaging; 2014 Feb 01; 39(2):427-33. PubMed ID: 23677620 [Abstract] [Full Text] [Related]
18. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine. Fink C, Bock M, Kiessling F, Lichy MP, Krissak R, Zuna I, Schmähl A, Delorme S, Kauczor HU. J Magn Reson Imaging; 2004 Feb 01; 19(2):202-8. PubMed ID: 14745754 [Abstract] [Full Text] [Related]